Therapeutic efficacy and toxicity of In-111-DTPA-D-Phe-octreotide in patients with advanced neuroendocrine tumors.

被引：0
|
作者：
Schipper, ML [1 ]
Gotthardt, M [1 ]
Behe, M [1 ]
Arnold, R [1 ]
Behr, TM [1 ]
机构：
[1] Univ Marburg, D-35032 Marburg, Germany
来源：
JOURNAL OF NUCLEAR MEDICINE | 2003年 / 44卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
446
引用
收藏
页码：137P / 137P
页数：1
相关论文
共 50 条
  • [31] RADIOTHERAPY WITH A RADIOLABELED SOMATOSTATIN ANALOG, [IN-111-DTPA-D-PHE(1)]-OCTREOTIDE
    KRENNING, EP
    KOOIJ, PPM
    BAKKER, WH
    BREEMAN, WAP
    POSTEMA, PTE
    KWEKKEBOOM, DJ
    OEI, HY
    DEJONG, M
    VISSER, TJ
    REIJS, AEM
    LAMBERTS, SWJ
    MOLECULAR AND CELL BIOLOGICAL ASPECTS OF GASTROENTEROPANCREATIC NEUROENDOCRINE TUMOR DISEASE, 1994, 733 : 496 - 506
  • [32] Blood cell counts during treatment of neuroendocrine tumors with [111-In-DTPA]octreotide
    van Hagen, PM
    Valkema, R
    Tse, WK
    Kwekkeboom, DJ
    de Herder, WW
    Hooykaas, H
    Krenning, EP
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 1999, 26 (09): : 1207 - 1207
  • [33] Radiation doses deriving from patients undergoing 111In-DTPA-d-Phe-1-octreotide scintigraphy
    Amir Kurtaran
    Josef Pfreitfellner
    Peter Schaffarich
    Peter Smith-Jones
    Bruno Niederle
    Markus Raderer
    Irene Virgolini
    Helmar Bergmann
    Ernst Havlik
    European Journal of Nuclear Medicine, 1997, 24 : 1298 - 1300
  • [34] Radiation doses deriving from patients undergoing 111In-DTPA-D-Phe-1-octreotide scintigraphy
    Cormack, J
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 1998, 25 (04): : 442 - 442
  • [35] Radiation doses deriving from patients undergoing In-111-DTPA-D-Phe-1-octreotide scintigraphy
    Kurtaran, A
    Pfreitfellner, J
    Schaffarich, P
    SmithJones, P
    Niederle, B
    Raderer, M
    Virgolini, I
    Bergmann, H
    Havlik, E
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 1997, 24 (10) : 1298 - 1300
  • [36] INVIVO APPLICATION OF [IN-111-DTPA-D-PHE1]-OCTREOTIDE FOR DETECTION OF SOMATOSTATIN RECEPTOR-POSITIVE TUMORS IN RATS
    BAKKER, WH
    KRENNING, EP
    REUBI, JC
    BREEMAN, WAP
    SETYONOHAN, B
    DEJONG, M
    KOOIJ, PPM
    BRUNS, C
    VANHAGEN, PM
    MARBACH, P
    VISSER, TJ
    PLESS, J
    LAMBERTS, SWJ
    LIFE SCIENCES, 1991, 49 (22) : 1593 - 1601
  • [37] HUMAN BIODISTRIBUTION OF [IN-111]DIETHYLENETRIAMINEPENTAACETIC ACID (DTPA)-D-[PHE(1)]-OCTREOTIDE AND PEROPERATIVE DETECTION OF ENDOCRINE TUMORS
    OHRVALL, U
    WESTLIN, JE
    NILSSON, S
    WILANDER, E
    JUHLIN, C
    RASTAD, J
    AKERSTROM, G
    CANCER RESEARCH, 1995, 55 (23) : S5794 - S5800
  • [38] DISTRIBUTION AND ELIMINATION OF THE SOMATOSTATIN ANALOG (IN-111-DTPA-D-PHE(1))-OCTREOTIDE (OCTREOSCAN111)
    ARNBERG, H
    WESTLIN, JE
    HUSIN, S
    NILSSON, S
    ACTA ONCOLOGICA, 1993, 32 (02) : 177 - 182
  • [39] Peptide receptor radionuclide therapy with [indium-111-DTPA-D-PHE]-octreotide (OC).
    Krenning, EP
    Valkema, R
    Kooij, PPM
    Breeman, WAP
    Bakker, WH
    deHerder, WW
    vanEijck, CHJ
    Kwekkeboom, DJ
    deJong, M
    Pauwels, S
    JOURNAL OF NUCLEAR MEDICINE, 1997, 38 (05) : 167 - 167
  • [40] Radiation doses deriving from patients undergoing 111In-DTPA-D-Phe-1-octreotide scintigraphy -: Reply
    Smith-Jones, PM
    Havlik, E
    Kurtaran, A
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 1998, 25 (04): : 443 - 444
12345